2pPP14. High-frequency stimulation in tinnitus treatment.
Session: Tuesday Afternoon, Dec 04
Author: Martin L. Lenhardt Location: Prog. in Biomed. Eng., Virginia Commonwealth Univ., Box 980158 MCV, Richmond, VA 23298-0168 Author: Douglas G. Richards Location: Prog. in Biomed. Eng., Virginia Commonwealth Univ., Box 980158 MCV,Prog. in Biomed. Eng., Virginia Commonwealth Univ., Box 980158 MCV, Richmond, VA 23298-0168 Author: Alan G. Madsen Location: Prog. in Biomed. Eng., Virginia Commonwealth Univ., Box 980158 MCV,Prog. in Biomed. Eng., Virginia Commonwealth Univ., Box 980158 MCV, Richmond, VA 23298-0168 Author: Abraham Shulman Location: Martha Entenmann Tinnitus Res. Ctr., Brooklyn, NY 11203 Author: Barbara A. Goldstein Location: Martha Entenmann Tinnitus Res. Ctr., Brooklyn, NY 11203 Author: Robert Guinta Location: Martha Entenmann Tinnitus Res. Ctr., Brooklyn, NY 11203
Abstract:
Limited but convincing evidence suggests neural plasticity plays a role in
the development and maintenance of tinnitus. Tinnitus is generally pitch matched
with high frequencies (<6kHz) and is often associated with very hearing
loss, although the conventional audiometric thresholds may be normal or near
normal. It is hypothesized that the brain experiences high-frequency air
conduction auditory deprivation and this is a causative factor in tinnitus. If
the low-pass middle ear is circumvented by bone conduction stimulation, residual
high-frequency receptors in the cochlea can again be activated. High-frequency
bone conduction transducers were fabricated to deliver frequencies from 6 to 40
kHz. The transducers were aluminum ceramic bimorphs with circular topology which
were heavily damped by mass loading to the mastoid with resonances at 9 and 39
kHz. Ten subjects with persistent tinnitus were selected to listen to
proprietary high-frequency patterned stimulation for two half-hour sessions for
4 weeks. Exit questionnaires revealed satisfaction with tinnitus relief in the
majority (60%) with residual inhibition lasting on the order of weeks (mean=1.5
weeks). Encouraged by these findings, more extensive trials are underway to
explore the efficacy of high-frequency bone conduction treatment in central
tinnitus.